The Malaysian Journal of Analytical Sciences Vol 17 No 2 (2013): 310 – 325

 

 

 

SPECTROPHOTOMETRIC DETERMINATION OF LAMOTRIGINE IN PHARMACEUTICAL PREPARATIONS AND URINE SAMPLES USING BROMOTHYMOL BLUE AND BROMOPHENOL BLUE

 

(Penentuan Spektrofotometrik Lamotrigina dalam Persediaan Farmaseutikal dan Sampel Urin Mengunakan Bromotimol Biru dan Bromofenol Biru)

 

Fadhil M. Najib*, Kosar H. H. Aziz

 

Chemistry Department, College of Science,

Sulaimani University, Sulaimani, Kurdistan Region, Iraq

 

*Corresponding author: fadhil.najib@univsul.net

 

 

Abstract

Two simple and sensitive spectrophotometric methods have been developed for the determination of the antiepileptic drug lamotrigine (LMT) in pharmaceutical preparations and urine samples.  The methods are based on the interaction of LMT with two sulphonphthalein dyes, namely, bromothymol blue (BTB) and bromophenol blue (BPB) in dichloromethane (DCM) medium to form stable and yellow-colored ion-pairs with  λmax 410 and 413 nm respectively. The ion-pair LMT-BPB has been extracted from aqueous solutions at pH 3.25±0.25 using DCM; while LMT-BTB ion-pair was directly prepared in DCM. Interferences from the compounds of the urine samples, in case of LMT-BPB were removed using a suppressing solution (S.S.) prepared from the salts of the interfering ions.  In LMT-BTB method, the urine of normal person not taking LMT, was used as a blank to remove the effect of interferences.  Under optimum conditions, the calibration curve of LMT-BTB was linear over the range of 1–12 µg.ml-1, ε =1.97×104 L.mole-1.cm-1, r2 = 0.9983, and D.L of 0.13 µg.ml-1. The corresponding values for (LMT-BPB) ion-pair were 0.5–12 µg.ml-1 linear range, ε =1.92× 104,  r2= 0.9980, and D.L= 0.24 µg.ml-1.  The stoichiometry of the ion-pairs were found to be 1:1, based on Job’s , mole ratio and slope ratio methods.  The recoveries (%R) for both methods were in the range of 97%-101.8% and 95%-97.1% with RSD ≤ 1.68% and 3.1% respectively.  For LMT- spiked urine samples, the recoveries were 98.5%- 106.6% with RSD ≤ 1.66%. Interferences from phenobarbital and carbamazepine were in the range of 25 – 40 folds.  Statistical comparison of the results with a published method using F and t-tests showed no significant differences between each of the two methods and the reported one at 95% confidence level.  A standard addition method, gave high accuracy with LMT-BPB method.  The proposed methods were successfully applied for the determination of LMT in pharmaceutical preparation and urine samples. 

 

Keywords:  lamotrigine, bromothymol blue, bromophenol blue, farmaceutical formulation, urine sample

 

References

1.        Griner-sosanko E, Lower DR, Virji MA, Kraswski MD. Simultaneous determination of lamotrigine, zonisamide and carbamazepine in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2007; 21: 225-228

2.        El-Enany NM, El-Sherbiny DT, Abdelal AA, Belal FF. Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde. J. Fluorescence. 2010; 20: 463-472

3.        Vinay KB, Revanasiddappa HD, Rajendraprasad N. Development and validation of spectrophotometric methods for the sensitive and selective determination of lamotrigine in pharmaceuticals using bromocresol purple. J. Food and Drug Anal. 2009; 17: 424-433.

4.        Rajendraprasad N, Basavaiah K, Vinay KB. Micro and nanogram determination of lamotrigine in pharmaceuticals by visible spectrophotometry using bromophenol blue. Indian J. Chem Technol. 2010; 17: 220-228.

5.        Youssef NF, Taha EA. Development and validation of spectrophotometric, TLC and HPLC methods for the determination of lamotrigine in presence of its impurity. Chem. Pharm. Bull. 2007; 55: 541-545

6.        Rajendraprasad N, Basavaiah K, Vinay KB. Sensitive spectrophotometric determination of lamotrigine in bulk drug and pharmaceutical formulation using bromocresol green. Ecl. Quim. Säopaulo 2010; 35: 55-66.

7.        Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC. Lamotrigine and therapeutic drug monitoring.  Br J ClinPharmacol. 1998: 46: 547-551.

8.        Lee W, Kim JH, Kim HS, Kwon OH, Lee BI, Heo K. Determination of lamotrigine in human serum by high-performance liquid chromatography-tandem mass spectrometry.Neurol Sci.2010; 14: 1–4.

9.        Puvvada PK, Murugan VG, Kumar SV, Padarthi PK. RP-HPLC Method Development and Validation of Lamotrigine. Derpharma Chemical 2010; 2: 104-108.

10.     Vidya SK, Prsanth NY, Suresh S, Anusha C, Somnath D, Aneela S. A new simultaneous RP-HPLC method for development and validation of lamotrigine tablets. J. Chem. Pharm. Res., 2011; 3: 651-658.

11.     Contin M, Mohamed S, Candela C, Albani F, Riva R, Baruzzi A. Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.  J. Chromatogr B: Anal Technol in the Biomed and Life Sci. 2010; 878: 461-465.

12.     Queiraz ME, Silva SM, Carvalbo D, Lancas FM. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD.J.Chromatogr. Sci., 2002; 40: 219- 223.

13.     Gupta VK, Singh AK, Gupta B. Development of membrane electrodes for selective determination of some antiepileptic drugs in pharmaceuticals, plasma and urine. Anal. BioanalChem. 2007; 389: 2019- 2028.

14.     Dominguez-Renedo O, Arcos Martinez M.J, Burgoa Calvo ME. Determination of lamotrigine by adsorptive stripping voltammetry using silver nanoparticle-modified carbon screen-printed electrodes.   Talanta 2007; 74:59- 64. 

15.     Dominguez-Renedo O, Burgoa Calvo ME, Arcos Martinez MJ. Determination of lamotriginein pharmaceutical preparations by adsorptive stripping voltammetry using screen printed electrodes. Sensors. 2008; 8: 4201- 4212.

16.     Navdeep S, Koyal S. Quantitative determination of lamotrigine in bulk and dosageformby UV spectrophotometry. J. Appl. Pharm. Sci., 2011; 1: 113-116.

17.     Alizadeh N., Khakinahad R., Jabbari A.; Pharmazie, Sectrophotometric determination of lamotrigine in pharmaceutical preparations and urine by charge-transfer complexation. J. Pharm. Sci. 2008, 63, 791–795.

18.     Sevgi Tatar Ulu. Sensitive and Simple Spectrophotometric Method for the Determination of Lamotrigine in Pure and Pharmaceutical Preparations of Charge-transfer Complex. Rev.Chim.(Bucharest). 2011; 62: 261-264.

19.     Bishop E: Indicators. 1st.Ed. Germany: Pergamon Press; 1972.

20.     Perrin DD, Boyd Dempsey: Buffers for pH and Metal Ion Control. 1st.Ed. Chapman and Hall;1974.

21.     Abolfathi Z, Belanger PM, Gilbert M, Rouleau JR. Improved high-performance liquid chromatographic assay for the stereoselective determination of mexiletine in plasmaJ.Chromatogr.. 1992; 579: 366.

22.     Ranjna C: Practical Clinical Biochemistry, methods and interpretations, 3rd. Ed. RK Yadav; 2003.

 

Previous                    Content                    Next